What Agteria Biotech does

Agteria Biotech AB is a Stockholm-based climate biotech startup founded in 2023 that develops enzyme inhibitor molecules designed to reduce enteric methane emissions from cattle and other livestock. The company's core technology targets the enzymatic processes in ruminant digestion that produce methane, with the stated aim of cutting 1% of global greenhouse gas emissions by 2035 through a single scalable product solution. The company is currently advancing its novel molecule through regulatory approval and safety studies rather than commercial sales.

Agteria's product portfolio is concentrated on a single core asset — a methane-reducing feed additive for cattle — positioned as a scalable and cost-effective alternative to existing enteric methane reduction approaches. The technology is described as a novel enzyme inhibitor architecture developed by a team with deep expertise in organic chemistry, biochemistry, and drug discovery. As of the available data, no patents or trademarks have been publicly disclosed, and the product is not yet commercially available.

Agteria is pre-revenue, with a planned revenue model based on one-time product licensing to livestock operations, likely distributed via enterprise field sales to large-scale cattle operations and agricultural enterprises following regulatory approval. The company has raised approximately €7.4 million to date across a €1.4M pre-seed round (Norrsken Launcher, March 2024) and a €6M seed round co-led by AgriZeroNZ and Industrifonden (February 2025), with participation from Mudcake. It operates with a lean 7-person team from Norrsken House in Stockholm and is pursuing visibility through the AHNTI EU 2026 Innovation Showcase.

Name

Agteria Biotech

Legal name

Agteria Biotech AB

Website

https://agteria.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Agteria Biotech is a Stockholm-based climate biotech startup developing a novel enzyme inhibitor to reduce methane emissions from cattle, targeting livestock farmers and agricultural enterprises ahead of regulatory approval and commercialization.

Ownership category

akta.pro rank

Product category

Agricultural Biotechnology / Livestock Methane Reduction

NAICS

Animal Food Manufacturing (3111)

SIC

Agricultural Prod-Livestock & Animal Specialties (200)

akta.pro primary industry

Medicated & Functional Ruminant Feed (Ionophores, Buffers, Yeast/Probiotics, Mycotoxin Binders) (AFADAAAL)

akta.pro secondary industry

Enzymes & Digestibility Enhancers (Phytase, NSP enzymes) (AFADAKAD)

Keywords

• Livestock feed additives
• Methane emission reduction
• Enzyme inhibitor technology
• Agricultural biotechnology
• Climate biotech solutions

Headquarters

HQ city

Stockholm

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Product Sales (Planned): Agteria Biotech is in the pre-revenue stage, focused on developing its methane reduction product for cattle and obtaining regulatory approval. The company raised €1.4M in pre-seed funding (2024) and €6M in seed funding (2025) to support R&D, regulatory approvals, and safety studies. Revenue generation is expected through product sales to livestock operations once regulatory approval is secured.

Go-to-market motion1 record

Marketing channels1 record

Core offering

Agteria Biotech is developing a novel enzyme inhibitor molecule designed to reduce methane emissions from cattle by blocking the enzymatic pathways in ruminant digestion that produce methane. The product is intended as a scalable, cost-effective feed additive for livestock operations and is currently advancing through regulatory approval and safety studies before commercial launch.

Product overview

Agteria Biotech offers a single unified product focused on methane emission reduction for cattle. The core offering is a novel enzyme inhibitor molecule designed to block methane production in livestock, targeting agricultural greenhouse gas emissions as a climate change solution.

Differentiator

Problem solved

Functional benefit

Products and services

• Methane Emission Reduction Solution for Cattle A scalable, cost-effective enzyme inhibitor molecule designed to reduce methane emissions from cattle by targeting the enzymatic pathways in ruminant digestion that produce methane. The product is intended for cattle farmers and large-scale livestock operations and is currently undergoing regulatory approval and safety studies prior to commercialization.

Quantifiable outcome

• Aims to reduce 1% of global emissions by 2035 through widespread adoption of methane reduction technology in livestock

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• DSM-Firmenich (Bovaer): Markets Bovaer (3-NOP), the leading approved feed additive for enteric methane reduction in dairy and beef cattle. Most directly comparable competitor — same target problem, same delivery mechanism (feed additive), same customer base (cattle farmers and dairy integrators).
• Mootral: Develops natural feed-additive formulations (citrus and garlic extracts) targeting enteric methane reduction in cattle. Closely comparable on mechanism class (feed-additive methane inhibitor) and target customer (dairy and beef producers).
• Blue Ocean Barns: Develops Brominata, an Asparagopsis-based (red seaweed) feed additive for enteric methane reduction in cattle. Comparable as a methane-reducing cattle feed additive approaching commercial deployment, with a different active ingredient than Agteria's enzyme inhibitor.
• CH4 Global: Commercializes Asparagopsis-based feed supplements (Methane Tamer) for cattle and sheep to cut enteric methane. Comparable on product class (feed-additive methane inhibitor) and customer segment (livestock industry).

Emerging players

• Eligo Bioscience: Pioneers microbiome-engineering therapeutics that could be applied to modulate the rumen microbiome and reduce methane. Comparable as an emerging biotech using novel biology to address enteric methane in livestock.
• ArkeaBio: Developing a methane-reducing vaccine for ruminants, taking a different mechanism (immunological) but targeting the same enteric methane problem in cattle and sheep. Comparable as a biotech pursuing novel biological routes to livestock methane reduction.
• Zelp (Zero Emissions Livestock Project): Develops wearable methane-capture devices for cattle rather than feed additives. Comparable as a cattle-methane-reduction startup serving the same dairy/beef customers, though addressing emissions capture post-production rather than at the digestive stage.
• Synergraze: Australia-based developer of Asparagopsis-derived feed supplements for grazing livestock. Comparable as a methane-reducing feed-additive company targeting cattle and sheep producers in Oceania — overlapping with Agteria's market opportunity via AgriZeroNZ-backed channels.
• Symbrosia: Hawaii-based startup developing Asparagopsis seaweed-based feed additives to reduce enteric methane in livestock. Comparable as an early-stage methane-reducing feed-additive company targeting the same cattle and dairy industry opportunity.

Broad incumbents

• Cargill: Global animal nutrition and feed giant with growing interest in methane-reducing feed solutions and partnerships with companies like Bovaer's distributor. Comparable as a broad incumbent in the cattle feed market and a likely competitor, partner, or acquirer for emerging methane-reduction technologies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agteria Biotech